Filing Details
- Accession Number:
- 0001415889-21-004864
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-13 16:03:10
- Reporting Period:
- 2021-10-11
- Accepted Time:
- 2021-10-13 16:03:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477845 | Annovis Bio Inc. | ANVS | Pharmaceutical Preparations (2834) | 262540421 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733680 | Claudine Bruck | C/O Annovis Bio, Inc. 1055 Westlakes Drive, Suite 300 Berwyn PA 19312 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-11 | 181 | $27.66 | 6,067 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
